Clinical trial
Trial of D-Cycloserine in Schizophrenia
NCT00000371 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00000371 |
|---|---|
| Title | Trial of D-Cycloserine in Schizophrenia |
| Official title | A Six Month, Placebo-Controlled Trial of D-Cycloserine Co-Administered With Conventional Antipsychotics in Schizophrenia Patients |
| Lead sponsor | Massachusetts General Hospital, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | D-cycloserine, Placebo |
| Enrollment | 60 |
| Start date | Aug 1, 1996 |
| Primary completion | Apr 1, 2002 |
| Completion | Apr 1, 2002 |
| First posted | Nov 3, 1999 |
| Last update posted | Sep 10, 2014 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: